Risks and benefits of FDA approved drug to treat Alzheimer’s disease
Published: Jan. 9, 2023 at 6:28 PM CST
WASHINGTON D.C. (KCRG) - The FDA approved a drug meant to slow the progression of Alzheimer’s disease, but there are limitations and risks.
KCRG-TV9′s Nicole Agee explains the results of that study and the risks and benefits for Alzheimer’s patients.
Copyright 2023 KCRG. All rights reserved.
